Sign up Australia
Proactive Investors - Run By Investors For Investors

Cosmos Holdings transfers its interest in Marathon Global to a cannabis investment firm

As part of the deal, Cosmos will still distribute Marathon Global's line of medical cannabis products
a vial of medical marijuana
Cosmos has a trans-European network of more than 160 clients and vendors

Pharmaceutical wholesaler Cosmos Holdings Inc (OTCQB:COSM) announced Tuesday that it has transferred its interest in the medical cannabis group Marathon Global to the investment firm Kaneh Bosm BioTechnology Inc (CSE:KBB).

Under the terms of the share exchange agreement, Cosmos has swapped its undisclosed stake in Marathon Global for 10 million shares of Kaneh Bosm, a Canadian-listed investment firm that specializes in the acquisition of marijuana projects and cannabis-related companies.

Cosmos will control about 7% of the 141,219,108 shares of stock that Kaneh Bosm issued.

As part of the deal, Cosmos will still distribute Marathon Global’s line of medical cannabis products as well as its cannabis derivatives to its clients in countries where medical cannabis is approved for sale.

BIG PICTURE: Cosmos Holdings focuses on Europe as it expands its global wholesale pharmaceutical business

“I am pleased to announce this agreement will provide Cosmos with additional product lines, all of which we anticipate will increase revenues and profitability on a global scale,” said Cosmos CEO Gregory Siokas in a statement.

Based in Chicago, Cosmos Holdings is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki, Greece and Harlow, UK. The company has a trans-European network of over 160 clients and vendors and conducts business in Germany, the United Kingdom, Ireland, the United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, Netherlands, and Greece.

Kaneh Bosm specializes in the acquisition of marijuana projects and cannabis-related companies while Marathon Global is a private Canadian company specializing in the supply of cannabis.

The use of cannabis for medical purposes is slowly being accepted by governments, with countries such as the Netherlands, Italy and Germany taking the lead with early adoption of regulations. Canada recently legalized the recreational use of marijuana.

Cosmos Holdings shares held steady at US$6.70 in morning trade.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full COSM profile View Profile

Cosmos Holdings Inc Timeline

Article
July 03 2018

Related Articles

picture of cannabis plants
March 24 2018
Control of the supply chain offers operational advantages and financial benefits.
woman at a microscope
August 02 2018
Currently undergoing phase III clinical trials, AP101 is being developed to treat Epidermolysis Bullosa, a condition which occurs prominently in children and makes skin fragile to even the faintest touch
Vial of pills
June 25 2018
Cosmos is a modern company, but the trade routes it relies on are ancient

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use